missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human UACA (aa 870-972) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (61%), Rat (61%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-65361 (PA5-65361. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Regulates APAF1 expression and plays an important role in the regulation of stress-induced apoptosis. Promotes apoptosis by regulating three pathways, apoptosome up-regulation, LGALS3/galectin-3 down-regulation and NF-kappa-B inactivation. Regulates the redistribution of APAF1 into the nucleus after proapoptotic stress. Down-regulates the expression of LGALS3 by inhibiting NFKB1.
Specifications
Specifications
| Accession Number | Q9BZF9 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 55075 |
| Name | Human UACA (aa 870-972) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 2700059D02Rik; beta-actin binding protein betaCAP73; beta-actin-binding protein; BetaCAP73; Kiaa1561; nuclear membrane binding protein; nuclear membrane binding protein NUCLING; nuclear membrane-binding protein; Nucling; RGD1560011; Uaca; uveal autoantigen; uveal autoantigen with coiled coil domains and ankyrin repeats; uveal autoantigen with coiled-coil domains and ankyrin repeats; Uveal autoantigen with coiled-coil domains and ankyrin repeats protein |
| Common Name | UACA |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction